GLYCABEN
Assay, Glycosylated Hemoglobin
EXOCELL, INC.
The following data is part of a premarket notification filed by Exocell, Inc. with the FDA for Glycaben.
Pre-market Notification Details
| Device ID | K893453 |
| 510k Number | K893453 |
| Device Name: | GLYCABEN |
| Classification | Assay, Glycosylated Hemoglobin |
| Applicant | EXOCELL, INC. 3508 MARKET ST., SUITE 420 Philadelphia, PA 19104 |
| Contact | Cohen, Md |
| Correspondent | Cohen, Md EXOCELL, INC. 3508 MARKET ST., SUITE 420 Philadelphia, PA 19104 |
| Product Code | LCP |
| CFR Regulation Number | 864.7470 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1989-05-03 |
| Decision Date | 1989-10-23 |
Trademark Results [GLYCABEN]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GLYCABEN 73835891 1642560 Dead/Cancelled |
EXOCELL, INC. 1989-11-03 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.